LADENBURG THALM/SH SH Initiates Coverage on Autonomix Medical (NASDAQ:AMIX)

Stock analysts at LADENBURG THALM/SH SH started coverage on shares of Autonomix Medical (NASDAQ:AMIX) in a report released on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $1.40 price target on the stock. LADENBURG THALM/SH SH’s price objective would suggest a potential upside of 92.57% from the stock’s previous close.

Autonomix Medical Trading Up 8.5 %

Shares of AMIX stock traded up $0.06 on Tuesday, reaching $0.73. 1,422,854 shares of the company were exchanged, compared to its average volume of 2,031,304. The company has a quick ratio of 9.27, a current ratio of 9.27 and a debt-to-equity ratio of 0.20. The business has a 50-day moving average price of $0.83 and a 200 day moving average price of $2.09. Autonomix Medical has a 1 year low of $0.51 and a 1 year high of $7.60.

Autonomix Medical (NASDAQ:AMIX) last posted its earnings results on Tuesday, August 13th. The company reported ($0.14) earnings per share for the quarter.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.